EVIDENCE LIBRARY
Cancer–COVID Cohort Reported More Anticipatory Benzodiazepine Prescribing With Palliative-Team Involvement
A European cohort described care planning and symptom-control prescribing during the first pandemic wave. Anticipatory prescribing did not establish that every prescribed dose was administered.
A European cohort described care planning and symptom-control prescribing during the first pandemic wave. Anticipatory prescribing did not establish that every prescribed dose was administered.
The care comparison
Among 555 eligible patients with cancer and COVID-19, 206 received specialist palliative-team input. The study compared planning, support, prescribing, and discharge measures between referred and nonreferred groups.
End-of-life anticipatory benzodiazepine prescribing was more frequent in the palliative-team group, alongside opioid prescribing and other planning measures.
Referral is not random allocation
Patients referred to a specialist team may differ in symptoms, prognosis, goals, and care needs. The comparison cannot isolate the causal effect of the team or any single medicine.
An anticipatory order provides medication availability for a possible symptom; it is different from documented administration and observed effect. The paper cannot establish that benzodiazepines caused death or improved every patient’s comfort. For individual review, distinguish the order, actual doses, indication, response, and evolving goals of care rather than inferring exposure from prescribing alone.
Source paper
Original analysis of the supplied journal article, identified as PMC8419540.